1. Glycyrrhiza Genus: Enlightening Phytochemical Components for Pharmacological and Health-Promoting Abilities / J. Sharifi-Rad, C. Quispe, J. Herrera-Bravo [et al.] // Oxidative Medicine and Cellular Longevity. ‒ 2021. ‒ Vol. 2021. ‒ Art. 7571132. https://doi.org/10.1155/2021/7571132

2. Pharmacological Features of 18β-Glycyrrhetinic Acid: A Pentacyclic Triterpenoid of Therapeutic Potential / P. Shinu, G. L. Gupta, M. Sharma [et al.] // Plants. ‒ 2023. ‒ Vol. 12, N 5. – Art. 1086. https://doi.org/10.3390/plants12051086

3. Терпинская, Т. И. Противоопухолевые свойства глицирризиновой и глицирретовой кислоты / Т. И. Терпинская // Новости медико-биологических наук. – 2023. – Т. 23, № 3. – С. 235‒252.

4. Oncopreventive and oncotherapeutic potential of licorice triterpenoid compound glycyrrhizin and its derivatives: Molecular insights / R. Jain, M. A. Hussein, S. Pierce [et al.] // Pharmacological Research. – 2022. – Vol. 178. – Art. 106138. https://doi.org/10.1016/j.phrs.2022.106138

5. Advances in the roles of glycyrrhizic acid in cancer therapy / Y. Zhang, Z. Sheng, J. Xiao [et al.] // Frontiers in Pharmacology. – 2023. – Vol. 14. – Art. 1265172. https://doi.org/10.3389/fphar.2023.1265172

6. Chemopreventive and Anticancer Activity of Selected Triterpenoids in Melanoma / N. Dycha, M. Michalak-Tomczyk, J. Jachuła [et al.] // Cancers. – 2025. – Vol. 17, N 10. – Art. 1625. https://doi.org/10.3390/cancers17101625

7. Влияние бетулиновой кислоты и модуляторов кальциевого обмена на рост опухолевых клеток / Т. И. Терпинская, Т. Л. Янченко, М. А. Рубинская, Е. Ф. Полукошко // Биохимия и молекулярная биология. – 2024. – Т. 3, № 1. – С. 136–142.

8. Влияние антагонистов TRP-каналов и ингибиторов кальций-связывающих белков на противоопухолевый эффект производного бетулиновой кислоты in vitro / Т. И. Терпинская, К. В. Маркевич, М. А. Рубинская [и др.] // Новости медико-биологических наук. ‒ 2024. ‒ Т. 24, № 3. – С. 121‒122.

9. Calcium channels as pharmacological targets for cancer therapy / X. Liu, C. Feng, L. Yan [et al.] // Clinical and Experimental Medicine. – 2025. – Vol. 25, N 1. – Art. 94. https://doi.org/10.1007/s10238-025-01632-z

10. Pleiotropic Pharmacological Actions of Capsazepine, a Synthetic Analogue of Capsaicin, against Various Cancers and Inflammatory Diseases / M. H. Yang, S. H. Jung, G. Sethi, K. S. Ahn // Molecules. – 2019. – Vol. 24, N 5. – Art. 995. https://doi.org/10.3390/molecules24050995

11. Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression / A. Haustrate, C. Cordier, G. Shapovalov [et al.] // Cell Death and Disease. – 2024. – Vol. 15, N 6. – Art. 419. https://doi.org/10.1038/s41419-024-06809-0

12. Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness / H. Lee, J. W. Kim, D.-S. Lee, S.-H. Min // International Journal of Molecular Sciences. – 2020. – Vol. 21, N 19. – Art. 7379. https://doi.org/10.3390/ijms21197379

13. The calcium channel TRPC6 promotes chemotherapy-induced persistence by regulating integrin α6 mRNA splicing / D. Mukhopadhyay, H. L. Goel, C. Xiong [et al.] // Cell Reports. – 2023. – Vol. 42, N 11. – Art. 113347. https://doi.org/10.1016/j.celrep.2023.113347

14. Activated protein C and thrombin participation in the regulation of astrocyte functions / A. E. Ivanova, L. R. Gorbacheva, S. M. Strukova [et al.] // Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology. – 2014. – Vol. 8, N 1. – P. 50‒59. https://doi.org/10.1134/s1990747813050048

15. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays / T. Mosmann // Journal of Immunological Methods. – 1983. – Vol. 65, N 1–2. – P. 55–63. https://doi.org/10.1016/00221759(83)90303-4

16. Kamgar-Dayhoff, P. Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment / P. KamgarDayhoff, T. I. Brelidze // Oncotarget. – 2021. – Vol. 12, N 14. – P. 1406–1426. https://doi.org/10.18632/oncotarget.28010

17. M. An alternative assay to discover potential calmodulin inhibitors using a human fluorophore-labeled CaM protein / González-Andrade, M. Figueroa, R. Rodríguez-Sotres [et al.] // Analytical Biochemistry. – 2009. – Vol. 387, N 1. – P. 64–70. https://doi.org/10.1016/j.ab.2009.01.002

18. Khan, S. Z. The effects of phenothiazines and other calmodulin antagonists on the sarcoplasmic and endoplasmic reticulum Ca2+ pumps / S. Z. Khan, C. L. Longland, F. Michelangeli // Biochemical Pharmacology. – 2000. – Vol. 60, N 12. – P. 1797–1806. https://doi.org/10.1016/s0006-2952(00)00505-0

19. Chlorpromazine inhibits store-operated calcium entry and subsequent noradrenaline secretion in PC12 cells / S.-Y. Choi, Y.-H. Kim, Y.-K. Lee, K.‐T. Kim // British Journal of Pharmacology. – 2001. – Vol. 132, N 2. – Р. 411–418. https://doi.org/10.1038/sj.bjp.0703840

20. Neuroleptic Chlorpromazine Modulates Ca2+ Responses in Macrophages / Z. I. Krutetskaya, L. S. Milenina, V. G. Antonov, A. D. Nozdrachev // Doklady Biochemistry and Biophysics. – 2020. – Vol. 490, N 1. – P. 25–28. https://doi.org/10.1134/S160767292001010x

21. Sigma-1 Receptor Ligands Chlorpromazine and Trifluoperazine Attenuate Ca2+ Responses in Rat Peritoneal Macrophages / L. S. Milenina, Z. I. Krutetskaya, V. G. Antonov, N. I. Krutetskaya // Cell and Tissue Biology. – 2022. – Vol. 16, N 3. – P. 233–244. https://doi.org/10.1134/S1990519x22030075

22. Creamer, T. P. Calcineurin / T. P. Creamer // Cell Communication and Signaling. – 2020. – Vol. 18, N 1. – Art. 137. https://doi.org/10.1186/s12964-020-00636-4

23. Chen, L. Calcineurin in development and disease / L. Chen, M. Song, C. Yao // Genes and Diseases. – 2021. – Vol. 9, N 4. – P. 915–927. https://doi.org/10.1016/j.gendis.2021.03.002

24. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro / L. Gao, J. Dong, N.Zhang [et al.] // Anti-Cancer Agents in Medicinal Chemistry. – 2019. – Vol. 19, N 2. – P. 248–255. https://doi.org/10.2174/1871520618666181029170605

25. Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications / C. Flores, G. Fouquet, I. C. Moura [et al.] // Frontiers in Immunology. – 2019. – Vol. 10, – Art. 588. https://doi.org/10.3389/fimmu.2019.00588

26. Differential dose-response effect of cyclosporine A in regulating apoptosis and autophagy markers in MCF-7 cells / S. S. Siddiqui, R. Hodeify, S. Mathew [et al.] // Inflammopharmacology. – 2023. – Vol. 31, N 4. – P. 2049–2060. https://doi.org/10.1007/s10787-023-01247-4

27. Ruthenium red attenuates acute pancreatitis by inhibiting MCU and improving mitochondrial function / X. Yu, C. Dai, X. Zhao [et al.] // Biochemical and Biophysical Research Communications. – 2022. – Vol. 635. – P. 236–243. https://doi.org/10.1016/j.bbrc.2022.10.044

28. Jara-Oseguera, A. Ruthenium red: Blocker or antagonist of TRPV channels? / A. Jara-Oseguera // Cell Calcium. – 2024. – Vol. 119. – Art. 102874. https://doi.org/10.1016/j.ceca.2024.102874

29. Molecular details of ruthenium red pore block in TRPV channels / R. A. Pumro, J. J. De Jesús-Pérez, A. D. Protopopova [et al.] // EMBO Reports. – 2024. – Vol. 25, N 2. – P. 506–523. https://doi.org/10.1038/s44319-023-00050-0

30. Singh, P. Reversal in Cognition Impairments, Cholinergic Dysfunction, and Cerebral Oxidative Stress Through the Modulation of Ryanodine Receptors (RyRs) and Cysteinyl Leukotriene-1 (CysLT1) Receptors / P. Singh, B. Sharma // Current Neurovascular Research. – 2016. – Vol. 13, N 1. – P. 10–21. https://doi.org/10.2174/1567202612666151026105610

31. Saura, J. Microglial cells in astroglial cultures: a cautionary note / J. Saura // Journal of Neuroinflammation. ‒ 2007. – Vol. 4. – Art. 26. https://doi.org/10.1186/1742-2094-4-26